1. Home
  2. MDWD vs CMCM Comparison

MDWD vs CMCM Comparison

Compare MDWD & CMCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.52

Market Cap

214.9M

Sector

Health Care

ML Signal

HOLD

Logo Cheetah Mobile Inc. each representing fifty (50)

CMCM

Cheetah Mobile Inc. each representing fifty (50)

HOLD

Current Price

$5.27

Market Cap

176.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDWD
CMCM
Founded
2000
2009
Country
Israel
China
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
214.9M
176.8M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
MDWD
CMCM
Price
$16.52
$5.27
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$36.00
N/A
AVG Volume (30 Days)
91.0K
15.8K
Earning Date
05-20-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$48.92
$11.61
Revenue Next Year
$35.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.90
$3.65
52 Week High
$22.51
$9.44

Technical Indicators

Market Signals
Indicator
MDWD
CMCM
Relative Strength Index (RSI) 45.32 41.14
Support Level $14.90 $5.45
Resistance Level $18.49 $7.15
Average True Range (ATR) 0.63 0.32
MACD -0.07 0.01
Stochastic Oscillator 20.41 19.42

Price Performance

Historical Comparison
MDWD
CMCM

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

Share on Social Networks: